BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Manila
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:PST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/La_Paz
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
TZNAME:-04
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240606T130000
DTEND;TZID=America/New_York:20240606T140000
DTSTAMP:20240528T155815Z
CREATED:20240528T155815Z
LAST-MODIFIED:20240528T155815Z
UID:61299-1717678800-1717682400@globalbiodefense.com
SUMMARY:Modernized ClinicalTrials.gov Update
DESCRIPTION:ClinicalTrials.gov is the world’s largest database of privately and publicly funded clinical trials. NLM is in the final phases of a multi-year effort to modernize ClinicalTrials.gov delivering an improved user experience on an updated platform that will accommodate growth and enhance efficiency. \nDuring this webinar\, ClinicalTrials.gov staff will: \n\nShare updates on the overall modernization effort\,\nHighlight features of the modernized website\, and\nHelp users prepare for the retirement of the classic ClinicalTrials.gov.\n\nYou’ll also have an opportunity to submit questions to the speakers. \nPlease REGISTER in advance for this webinar. \nThis webinar is intended for the general public\, patients\, patient advocates\, data researchers\, data providers\, and anyone who accesses and uses the information found on ClinicalTrials.gov.
URL:https://globalbiodefense.com/event/modernized-clinicaltrials-gov-update/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240613
DTSTAMP:20240505T174927Z
CREATED:20240505T174844Z
LAST-MODIFIED:20240505T174927Z
UID:61169-1718064000-1718236799@globalbiodefense.com
SUMMARY:Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium
DESCRIPTION:The Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium will be held 11-12 June 2024 in Research Triangle Park and Chapel Hill\, North Carolina. \nThe Biomedical and Biodefense Support to the Warfighter track will focus on establishing dialogue between industry and academia-based technology innovators and military and government officials to address the current and future biomedical and biodefense needs of the military and the nation. \nMedical Support to the Warfighter will connect businesses in North Carolina with military and other federal agencies that require or purchase medical supplies\, equipment\, devices\, pharmaceuticals\, medical information technology and medical services. \nRepresentatives from the Departments of Defense\, Veterans Affairs and Health and Human Services\, their prime vendors and major contractors – from national commands and from bases\, commands and facilities in North Carolina – will highlight current technology or resource gaps and needs\, future requirements and procurement processes to supply military and federal medical facilities and agencies. \nAll medical-related businesses in North Carolina – large or small\, prime contractors\, subcontractors\, suppliers\, manufacturers and service providers – will benefit from briefings on military requirements\, procurement processes and supplier qualifications\, from informal networking with buyers and users\, and from exhibiting or viewing demonstrations of the latest medical technologies designed to support America’s warfighters. \nHighlighted sessions include: \n\nBreakthrough Technologies: Opportunities in Military Medicine and Biosecurity\nFunding the Next Generation of Medical\, Biomedical and Health Security Solutions – An Investor’s Take\nSustaining the Medical Treatment Facilities: Logistics\, Acquisition and R&D\nMedical Challenges in Large-Scale Combat Operations\nFederal Funding Vehicles\nEcosystem Partners and How They Can Help You\n\nEvents on 11 June will be held at the North Carolina Biotechnology Center\, 15 T. W. Alexander Drive\, Research Triangle Park\, North Carolina 27709. Events on 12 June will be held at the UNC Friday Center in Chapel Hill. \nThe event is hosted by the Office of US Senator Thom Tillis\, Office of US Senator Ted Budd\, the North Carolina Military Business Center and the North Carolina Biotechnology Center. \nPlease visit the Medical\, Biomedical & Biodefense: Support to the Warfighter Symposium website for more information.
URL:https://globalbiodefense.com/event/medical-biomedical-biodefense-support-to-the-warfighter-symposium/
LOCATION:The Friday Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27517\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240618
DTEND;VALUE=DATE:20240622
DTSTAMP:20240218T232724Z
CREATED:20240126T213043Z
LAST-MODIFIED:20240218T232724Z
UID:59704-1718668800-1719014399@globalbiodefense.com
SUMMARY:Global Health Security 2024
DESCRIPTION:The Global Health Security Conference 2024 will be held 18-21 June in Sydney\, Australia. \nGHS 2024 will bring together practitioners\, researchers\, educators\, representatives and decision-makers across the fields of public health\, medicine\, veterinary science\, agriculture\, government\, defense\, international relations\, sociology and anthropology to examine the progress made to date in strengthening health systems and identify the gaps and opportunities for enhancing the international community’s ability to respond more efficiently and effectively to future adverse health crises. \nThe Global Health Security Conference 2024 will promote a dynamic and contemporary program that will include a mixture of keynote panel presentations\, dedicated sessions\, and lively discussions and debate on the challenges that impact global health security. The 4-day conference will also include a series of workshops\, side events and panels including a two-day Military Civilian Health Security Summit. \nPlease visit the Global Health Security Conference 2024 event page for more information and to register.
URL:https://globalbiodefense.com/event/global-health-security-2024/
LOCATION:ICC Sydney\, 14 Darling Dr\, Sydney\, 2000\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240620
DTEND;VALUE=DATE:20240622
DTSTAMP:20240302T230224Z
CREATED:20240302T230140Z
LAST-MODIFIED:20240302T230224Z
UID:60498-1718841600-1719014399@globalbiodefense.com
SUMMARY:Phage Therapy 2024
DESCRIPTION:The 7th annual World Conference on Targeting Phage Therapy\, focusing on the latest phage research\, challenges\, and future directions\, is set to convene in Malta on 20-21 June 2024. \nThis event will gather leading experts\, researchers\, and healthcare professionals to discuss advancements in phage therapy applications. \nHighlighted agenda sessions include: \n\nExploration of phage\, phageome\, and phage therapy\nAnalysis of phages and hosts including recent developments\nExamination of microbiome & phageome interactions\, and their medical implications\nDiscussion on establishing a task force for phages and microbiome research\nTrends in phage therapy\, including overcoming resistance and clinical study design\nPresentations on academic and industrial innovations\nEthical and regulatory considerations in phage therapy\n\nPlease visit the Phage Therapy 2024 – 7th World Conference on Targeting Phage Therapy website for more information.
URL:https://globalbiodefense.com/event/phage-therapy-2024/
LOCATION:Corinthia Palace Malta\, De Paule Avenue\, San Anton\, BZN9023\, Malta
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240624
DTEND;VALUE=DATE:20240627
DTSTAMP:20240521T212940Z
CREATED:20240521T212923Z
LAST-MODIFIED:20240521T212940Z
UID:61251-1719187200-1719446399@globalbiodefense.com
SUMMARY:2024 CBRN Defense Conference and Exhibition
DESCRIPTION:The National Defense Industrial Association (NDIA) will host the 2024 CBRN Defense Conference and Exhibition from 24-26 June 2024 in Baltimore\, Maryland. \nThe goal of this conference is to gather stakeholders to promote education\, awareness\, and collaboration across the CBRN community and to foster innovation and rapid development of CBRN capabilities. \nHighlighted topics include: \n\nMedical Countermeasure Capabilities\nDHS CWMD and CBRN Strategy and Priorities\nHHS Biodefense Strategies and Priorities\nHealth of the Industrial Base\nUpdate on DoD Implementation of the Biodefense Posture Review\nDetection and Decision-Making Capabilities\nImplementing the National Biodefense Strategy\n\nHighlighted panel discussion participants include: \n\nRich Schoske\, Chief\, Diagnostics and Detection Division\, Defense Threat Reduction Agency\nCOL Robert Carter\, JPM CBRN Sensors\, JPEO-CBRND\nCAPT Mark Scheckelhoff\, US Public Health Service Commissioned Corps Director of Biodefense Preparedness\, DHS\nCSM Ken Graham\, USA (Ret)\, RDE Medical SME\, Anser\nDr. Jason Roos\, Scalable Solutions Mission Office Director\, ARPA-H\nBruce Goodwin\, JPL Enabling Technologies\, JPEO-CBRND\nDr. Shannon Greene\, Program Manager\, DARPA BTO\nDr. Christopher Houchens\, Director of the Division of CBRN Countermeasures\, BARDA\n\nPlease visit NDIA’s 2024 CBRN Defense Conference and Exhibition website for more information.
URL:https://globalbiodefense.com/event/2024-cbrn-defense-conference-and-exhibition/
LOCATION:Baltimore Convention Center\, 1 W Pratt St\, Baltimore\, MD\, 21201\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240624
DTEND;VALUE=DATE:20240629
DTSTAMP:20240206T175234Z
CREATED:20240206T175234Z
LAST-MODIFIED:20240206T175234Z
UID:59919-1719187200-1719619199@globalbiodefense.com
SUMMARY:ASV 2024 - Annual Meeting of the American Society for Virology
DESCRIPTION:The the 43rd Annual Meeting of the American Society for Virology will be held 24-28 June 2024 in Columbus\, Ohio. This event will bring together over 1\,600 virologists from around the world. \nHighlighted sessions and topics include: \n\nVirus-Host Interactions: Structural Virology\, Innate Antiviral Immunity\, and More\nArtificial Intelligence (AI)\, Machine Learning and Computation in Virology\nTranslating Basic Science to Development of Antivirals and Vaccines\nGlobal Eradication and Prevention: Obstacles and Successes\nMultiomic Characterization of Past Viral Infections\nTransmission and Pathogenesis of Emerging Arboviruses\nReveling the Tropism of Tick-Borne Flavivirus in the Brain Using Whole Tissue Ex Vivo Imaging\nMolecular and Immunological Drivers of Viral Disease Severity\nA Veterinary Virapalooza: Improving the control of Viral Diseases of Animals\nStudying Bats Using a One Health Lens: Bridging the Gap Between Bat Virology and Disease Ecology\nNavigating Virology Funding Opportunities with NIH\, NSF and USDA\n\nA virtual option of ASV 2024 is available containing recordings of the Satellite Symposiums\, Keynote\, Plenary Symposiums\, and the State-of-the-Art lectures. Abstract presentations\, both oral and poster\, will be in-person only and will not be recorded. \nPlease visit the ASV 2024 website for more information and to register.
URL:https://globalbiodefense.com/event/asv-2024-annual-meeting-of-the-american-society-for-virology/
LOCATION:Greater Columbus Convention Center\, 400 N High St\, Columbus\, Columbus\, OH\, 43215-2096\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240625T120000
DTEND;TZID=America/New_York:20240625T130000
DTSTAMP:20240624T175704Z
CREATED:20240521T200752Z
LAST-MODIFIED:20240624T175704Z
UID:61246-1719316800-1719320400@globalbiodefense.com
SUMMARY:What's in the RADx Data Hub?
DESCRIPTION:The NIH RADx Data Hub is one of the largest NIH COVID data collections available to researchers\, allowing them to explore\, access\, and analyze COVID-related data developed from over 150 studies through NIH RADx Initiative programs. \nThe NIH RADx Data Hub relaunched with an entirely new look and feel and exciting new analysis features. Join a virtual presentation on 25 June 2024 on the NIH RADx® study data collections accessible via the RADx Data Hub. \nIn this presentation\, representatives from RADx program Collection and Data Coordinating Centers ((C)DCCs) will highlight unique scientific domain areas. Presenters will discuss challenges\, illustrate their diverse study landscapes\, and overview impactful studies. RADx Data Hub Partners will then provide an overview of RADx data access requests for secondary analysis. \nPresenters and RADx Data Hub developers will be available for a live Question and Answer session\, and a recording of the event will be sent to all registrants.
URL:https://globalbiodefense.com/event/whats-in-the-radx-data-hub/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240702
DTEND;VALUE=DATE:20240705
DTSTAMP:20240219T001045Z
CREATED:20240219T000910Z
LAST-MODIFIED:20240219T001045Z
UID:60055-1719878400-1720137599@globalbiodefense.com
SUMMARY:INTERPOL Global Biosecurity Conference
DESCRIPTION:The inaugural INTERPOL Global Biosecurity Conference will be held 2-4 July 2024 in Lyon\, France. \nThe conference will bring together law enforcement and partner agencies\, biosecurity experts and academia from different regions and backgrounds to foster dialog\, discuss current and future biological threats\, good practices and challenges. \nThe overarching goal is to to define a set of recommendations based on the outcomes of each session that would support the law enforcement community’s efforts to strengthen biosecurity at the global level. \nINTERPOL invites biosecurity experts\, researchers and scholars to submit an abstract to join the selection procedure to potentially present your work during the conference. \nThis should be written on one of the subjects below: \n\nBiological threat landscape\nCritical infrastructure protection and targeted threats\nDual-use commodities and research in the fields of biotechnologies and life science\nLaw enforcement roles and interagency cooperation in response to biological incidents\nCapacity building efforts to prevent\, prepare and respond to biological threats and incidents\nOnline content impacting the bioterrorist threat\nTackling biological threats to animals and plants from a law enforcement perspective\nBiological threat actors\n\nAbstracts are currently due 8 March. Please visit the INTERPOL Global Biosecurity Conference website for the latest information.
URL:https://globalbiodefense.com/event/interpol-global-biosecurity-conference/
LOCATION:Lyon\, Lyon\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240722
DTEND;VALUE=DATE:20240724
DTSTAMP:20240926T165526Z
CREATED:20240622T152754Z
LAST-MODIFIED:20240926T165526Z
UID:61357-1721606400-1721779199@globalbiodefense.com
SUMMARY:Accelerating the Use of Pathogen Genomics and Metagenomics in Public Health
DESCRIPTION:The NASEM Forum in Microbial Threats will host a public workshop 22-23 July 2024 on Accelerating the Use of Pathogen Genomics and Metagenomics in Public Health.   to examine cases where genomics technologies have been applied successfully to disease surveillance and response\, highlight key characteristics of these technologies’ impact\, and identify potential opportunities for broader adoption in public health. \nHigh-throughput and increasingly affordable genome sequencing technologies have enabled the use of pathogen genomics and metagenomics as powerful data-driven disease surveillance approaches. These epidemiological tools have been critical in addressing emerging outbreaks and evolving pathogens from foodborne infections to SARS-CoV-2. This workshop will examine opportunities to integrate the use of pathogen genomics tools and techniques more broadly into the public health system to improve the rapidity and effectiveness of surveillance and response to diseases. \nAgenda items include: \n\nCurrent State of Pathogen Genomics in the U.S. Public Health System\nApplications of Pathogen Genomics in Public Health – State Level\, National Level\nGenomic Surveillance for Antimicrobial Resistance\nGenomic Sequencing to Inform Therapeutic Usage\nPathogen Genomics for Outbreak Epidemiology\nApplications of Pathogen Genomics in H5N1 Outbreak\nCurrent State of Infrastructure and Interoperability of Pathogen Genomics Data in the U.S\nIntegration of Data Streams to Augment Genomic Data\nPHA4GE Data Standards System and Structure – Application in South Africa\nData Processing Structures and Determining the Value of Sequenced Data\nConsiderations for Sovereignty and Governance of Pathogen Genomics Data on an International Scale\nDemocratization Efforts and Integration of Alternate Data Systems\nApplications for New Pathogen Detection and Limitations of Genomics Data\nPathogen Genomics in the Future of Public Health\n\nRegister to attend online or in person here. \nSource: National Academies of Sciences
URL:https://globalbiodefense.com/event/accelerating-the-use-of-pathogen-genomics-and-metagenomics-in-public-health/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240723T081500
DTEND;TZID=America/New_York:20240723T121500
DTSTAMP:20240926T165526Z
CREATED:20240722T154732Z
LAST-MODIFIED:20240926T165526Z
UID:61362-1721722500-1721736900@globalbiodefense.com
SUMMARY:Heritable Genetic Modification in Food Animals
DESCRIPTION:An ad hoc committee appointed by the National Academies to explore heritable genetic modifications of food animals will meet from 23-24 July 2024 to discuss Oversight and Food Safety Concerns Posed by Heritable Genetic Modification in Food Animals. \nThis committee will address methods for heritable genetic modifications and identify risks and health hazards to humans\, animals\, and the environment. Furthermore\, this study will identify challenges associated with long term effects of heritable genetic modifications and identification of study design challenges when researching heritable genetic modifications in food animals. Agenda topics include: \n\nRecent regulatory activities regarding HGM animals\nAllergenic potential of HGM animal food products\nScientific and legal aspects of proposed changes to Guidance for Industry\nMOU with FDA for coordinating oversight of HGM animals\nRisk assessment and demonstration of safety of foods from HGM animals\n\nThe public part of the workshop will take place from 8:15 AM- 12:15 PM Eastern. Register to participate via webcast here. Source: National Academies of Sciences
URL:https://globalbiodefense.com/event/heritable-genetic-modification-in-food-animals/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240815
DTSTAMP:20240926T165526Z
CREATED:20240722T152250Z
LAST-MODIFIED:20240926T165526Z
UID:61355-1723507200-1723679999@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:A National Academies committee will host a public information gathering session August 13-14\, 2024 featuring panels discussing the benefits and biosecurity concerns of AI-enabled biological design tools and biological data. \nThis is the first in-person meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. The open session of this information gathering meeting will include initial briefings containing information relevant to study issues. The committee will also meet in closed session for project planning and review of topics and speakers for remaining meetings. \nThis event is available to attend either in-person or online from 8:00 AM – 5:00 PM ET. This meeting will include initial briefings containing information relevant to study issues. Please register today to receive updates as they become available.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240826T143000
DTEND;TZID=America/New_York:20240826T160000
DTSTAMP:20240815T204408Z
CREATED:20240815T204408Z
LAST-MODIFIED:20240815T204408Z
UID:61760-1724682600-1724688000@globalbiodefense.com
SUMMARY:New Approaches to Vaccine Communications
DESCRIPTION:New Approaches to Vaccine Communications will be held on online on Monday\, August 26. \nEach fall and winter season\, public health professionals help their communities make informed decisions about vaccines through compelling and timely messages. This webinar will introduce newly tested messages to encourage routine and recommended vaccinations for children and adults. Attendees will access new messaging approaches that can inspire openness and curiosity about vaccines. \nTopics will include: \n\nMessages that build trust in vaccines among vaccine-hesitant people.\nUpdated 2024 guidance for annual vaccines\, including the flu and COVID-19.\nTools and tips for building trust with communities through innovative and accessible vaccine content.\n\nPlease visit the Public Health Communications Collaborative for more information or register here.
URL:https://globalbiodefense.com/event/new-approaches-to-vaccine-communications/
LOCATION:https://us06web.zoom.us/webinar/register/1417230409975/WN_yC4o5JcAS8yCUTEXIXiUbg?_hsmi=320066972#/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240905
DTEND;VALUE=DATE:20240907
DTSTAMP:20240505T185234Z
CREATED:20240505T185144Z
LAST-MODIFIED:20240505T185234Z
UID:61176-1725494400-1725667199@globalbiodefense.com
SUMMARY:APBA Annual Biorisk Conference 2024
DESCRIPTION:The 17th A-PBA Annual Biorisk Conference in conjunction with the BRAP 7th Annual Convention and 4th International Forum will be held 5-6 September in Quezon City\, the Philippines. Pre-conference events will be held 3-4 September. \nAbstracts are currently being accepted until 30 May for poster entries. Themes include: \n\nLaboratory biosafety and biosecurity\nBest practices in biorisk management\nInfection control\, patient safety and related fields\nOne Health and antimicrobial resistance\nEmerging biotechnology\nPublic health\nDual use research of concern\n\nPlease visit the BRAP website for more information.
URL:https://globalbiodefense.com/event/apba-annual-biorisk-conference-2024/
LOCATION:Crowne Plaza Manila Galleria\, Ortigas Ave\, Corner Asian Development Bank Ave\, Quezon City\, 1100\, Philippines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240920
DTEND;VALUE=DATE:20240924
DTSTAMP:20240209T035906Z
CREATED:20240209T035906Z
LAST-MODIFIED:20240209T035906Z
UID:59960-1726790400-1727135999@globalbiodefense.com
SUMMARY:8th World One Health Congress
DESCRIPTION:The Global One Health Community is organizing the 8th World One Health Congress in Cape Town\n20 September – 23 September 2024. \nThe Congress will bring together One Health stakeholders\, from science researchers\, policymakers\, representatives of international institutions\, civil society to the private sector from around the world to address one health science\, antimicrobial agents and resistance\, and science policy interface. \nPlease visit the 8th World One Health Congress website for more information on abstract submission and registration.
URL:https://globalbiodefense.com/event/8th-world-one-health-congress/
LOCATION:Cape Town International Convention Centre\, 1 Lower Long Street\, Cape Town\, 8001\, South Africa
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20240623T192520Z
CREATED:20240111T185900Z
LAST-MODIFIED:20240623T192520Z
UID:59604-1727049600-1727222399@globalbiodefense.com
SUMMARY:Clinton Global Initiative 2024 Meeting
DESCRIPTION:The Clinton Global Initiative 2024 Meeting will convene on 23-24 September 2024 in New York\, NY. \n\n\n\nThe CGI 2024 Meeting\, timed to be alongside the U.N. General Assembly\, will bring together business\, government\, and civil society leaders to build upon over 4\,000 Commitments to Action since CGI was first founded – driving progress on climate resilience\, inclusive economic growth and recovery\, health equity\, humanitarian response\, equality for women and girls\, and other issues. \n\n\n\nHighlights from the CGI 2023 Meeting program include: \n\n\n\n\nPresident Clinton opening CGI 2023 with a special conversation with His Holiness Pope Francis via remote link\, on what it takes to keep going on the most pressing global challenges of our time like climate change\, the refugee crisis\, the welfare of children\, and the mission and projects of the Bambino Gesù Children’s Hospital. Watch the full conversation between President Clinton and His Holiness Pope Francis here.\n\n\n\nSecretary Clinton and Treasury Secretary Janet Yellen discussing the care economy\, the economic response to the COVID-19 pandemic\, U.S. foreign policy\, and more in a fireside chat. Watch the full conversation between Secretary Clinton and Secretary Yellen here.\n\n\n\nDr. Chelsea Clinton and partners announcing the CGI Women and Girls pillar\, a core focus area for CGI aimed specifically and ambitiously at achieving full equality and equity for women and girls once and for all. Read more on the launch of the CGI Women and Girls pillar.\n\n\n\nThe launch of the CGI Ukraine Action Network with 19 CGI commitment-makers\, in a session featuring Olena Zelenska\, First Lady of Ukraine\, the recipient of the 2023 Clinton Global Citizen Award. Read more on the launch of the Ukraine Action Network.\n\n\n\n\nAbout the Clinton Global Initiative \n\n\n\nFounded by President Bill Clinton in 2005\, the Clinton Global Initiative is a community of doers representing a broad cross section of society and dedicated to the idea that we can accomplish more together than we can apart.  Through CGI’s unique model\, more than 10\,000 organizations have launched more than 4\,000 Commitments to Action — new\, specific\, and measurable projects and programs – that are making a difference in the lives of more than 500 million people in 180 countries. \n\n\n\nFor information about CGI 2024 and highlights from the CGI 2023 Meeting please visit clintonglobal.org/2024. Further details on the meeting\, including the theme\, programming\, and featured attendees\, will be announced in the coming months.
URL:https://globalbiodefense.com/event/clinton-global-initiative-2024-meeting/
LOCATION:New York City\, New York\, NY\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240928
DTSTAMP:20240528T152329Z
CREATED:20240528T152329Z
LAST-MODIFIED:20240528T152329Z
UID:61286-1727049600-1727481599@globalbiodefense.com
SUMMARY:Virtual AMR Codeathon
DESCRIPTION:The National Center for Biotechnology Information (NCBI) is joining forces with the National Institute of Allergy and Infectious Diseases (NIAID) to co-host a virtual codeathon\, Resistance is Futile: A codeathon to combat antimicrobial resistance\, which will take place September 23-27\, 2024. \nThis event is an opportunity to explore the National Database of Antibiotic Resistant Organisms (NDARO) and related AMR data with NCBI Pathogen Detection tools\, such as the Isolates\, MicroBIGG-E\, and Antibiotic Susceptibility Test (AST) Browsers to identify additional data that may be useful for your project.  \nDuring the week-long codeathon\, you will collaborate with your team to accomplish the following objectives:  \n\nIdentify loss-of-function genetic variations that contribute to AMR.\nFind and classify mobile genetic elements that contribute to AMR in draft genomes. Note: This work could integrate sequence data with epidemiological\, transmission\, and antibiotic sensitivity testing data to identify patterns and directions of co-migrating of AMR genes or plasmids.\nElucidate AMR biomarkers for historically hard-to-predict bacterial species (e.g.\, Acinetobacter\, Pseudomonas).\n\nLearn more at the NCBI’s Virtual AMR Codeathon website. Applications are due by 28 July.
URL:https://globalbiodefense.com/event/virtual-amr-codeathon/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240924T080000
DTEND;TZID=America/New_York:20240924T094500
DTSTAMP:20240810T141355Z
CREATED:20240810T141253Z
LAST-MODIFIED:20240810T141355Z
UID:61420-1727164800-1727171100@globalbiodefense.com
SUMMARY:Pandemics\, Climate\, Conflict: Preventing Future Shocks
DESCRIPTION:Pandemics\, Climate\, Conflict: Preventing Future Shocks is a hybrid UN General Assembly week side event hosted by the Pandemic Action Network (PAN)\, the Independent Panel for Pandemic Preparedness and Response\, and Resilience Action Network Africa (RANA). \nHow can this year’s UN Summit of the Future (Sept. 22-23) serve as a springboard for action in the year ahead? \nThis event will include former Heads of State and government\, senior policymakers\, and non-governmental leaders sharing their perspectives on the current political state of play\, opportunities\, and actions necessary to ensure we are prepared to respond to\, and prevent\, future global shocks. \nRSVP here.
URL:https://globalbiodefense.com/event/pandemics-climate-conflict-preventing-future-shocks/
LOCATION:United Nations Headquarters\, 405 E 45th St\, New York\, NY\, 10017\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240927T120000
DTEND;TZID=America/New_York:20240927T130000
DTSTAMP:20240927T002512Z
CREATED:20240927T002133Z
LAST-MODIFIED:20240927T002512Z
UID:61857-1727438400-1727442000@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:This is the 2nd information gathering meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. The open session of this information gathering meeting will include briefings containing information relevant to study issues followed by a discussion with the committee. \nThe convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This committee will consider the ways in which AI-enabled biological design tools and biological data sets for training AI can increase and mitigate biosecurity risks\, specifically on concerns of transmissible biological threats that could pose significant epidemic and pandemic-scale consequences. \nThe agenda includes a panel on high-performance computing in life sciences and biological data resources and infrastructure. \nThis meeting will be held over zoom. A recording of the open meeting will be available after it has ended.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences-3/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T090000
DTEND;TZID=America/New_York:20241001T120000
DTSTAMP:20240927T002512Z
CREATED:20240927T001306Z
LAST-MODIFIED:20240927T002512Z
UID:61856-1727773200-1727784000@globalbiodefense.com
SUMMARY:Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences
DESCRIPTION:This is the third in-person meeting of the consensus study\, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. \nThe open session of this information gathering meeting will include briefings containing information relevant to study issues. The committee will also meet in closed sessions to discuss the report. \nThe convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This committee will consider the ways in which AI-enabled biological design tools and biological data sets for training AI can increase and mitigate biosecurity risks\, specifically on concerns of transmissible biological threats that could pose significant epidemic and pandemic-scale consequences. \nHighlighted agenda topics include: \n\nUnderstanding Pathogenesis of Transmissible Biological Agents and Impact of AI\nOpportunities to Use AI in Medical Countermeasures Development\nHigh Performance Computing in the Life Sciences\n\nThis meeting will be held over zoom. A recording of the open meeting will be available after it has ended.
URL:https://globalbiodefense.com/event/assessing-and-navigating-biosecurity-concerns-and-benefits-of-artificial-intelligence-use-in-the-life-sciences-2/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T120000
DTEND;TZID=America/New_York:20241001T130000
DTSTAMP:20240927T000657Z
CREATED:20240927T000529Z
LAST-MODIFIED:20240927T000657Z
UID:61855-1727784000-1727787600@globalbiodefense.com
SUMMARY:Accelerating Drug Discovery with Machine Learning
DESCRIPTION:Advances in machine learning and its impacts on daily life have captured the imagination of headlines. However\, significant challenges abound in accelerating drug discovery with machine learning\, a field with many unknown unknowns. \nAs part of Advancing Drug Discovery: A Webinar Series of the National Academies of Sciences\, Engineering and Medicine\, a session on Accelerating Drug Discovery with Machine Learning will be held on Tuesday\, October 1st. \nPlease visit the National Academies’ website for more information.
URL:https://globalbiodefense.com/event/accelerating-drug-discovery-with-machine-learning/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241007
DTEND;VALUE=DATE:20241010
DTSTAMP:20240927T041344Z
CREATED:20240927T041238Z
LAST-MODIFIED:20240927T041344Z
UID:61865-1728259200-1728518399@globalbiodefense.com
SUMMARY:40th NRL Workshop on Infectious Disease Testing
DESCRIPTION:Australia’s 40th NRL Workshop on Infectious Disease Testing will be held 7-9 October in Melbourne \nExplore a comprehensive lineup of expert speakers and insightful sessions\, covering the latest advancements infectious diseases. \nHighlighted agenda topics include: \n\nEvaluation of the Roche Cobas HIV-1/HIV-2 Qualitative assay for the diagnosis of HIV-1\nThe Role of Diagnostics to Support Reaching the Unreached\nRapid POC self-tests for diagnosis of acute syphilis\nQuality control in diagnostic kits: Enhancing wellbeing through effective panel prep for HCV and HBV\nCapacity building for the diagnosis of Japanese encephalitis virus in Australia\nReview of syphilis serology tests and testing strategies\nThe complexities of diagnosing congenital syphilis infections\nRapid syndromic testing in the ED\nPreparing for the next pandemic\nNew tools in the evolving battle against respiratory pathogens\nOptimizing HRP conjugated antigens for SARS-CoV-2 total antibody detection applications in serological surveys\n\nPlease visit the NRL Workshop on Infectious Disease Testing website for more information. \n  \n\nABOUT NRL \nAustralia’s National (Serology) Reference Laboratory (NRL) was first established as part of the Australian Government’s HIV and AIDS strategy in 1985 and later that year was designated as a World Health Organisation (WHO) Collaborating Centre for Diagnostics and Laboratory Support for HIV and AIDS and Other Blood-borne Infections. \nOver time\, NRL has emerged as a global leader in the science of quality for infectious disease testing and we believe that good science makes all the difference because the outcome of testing has such a significant impact on individuals and the community. \n 
URL:https://globalbiodefense.com/event/40th-nrl-workshop-on-infectious-disease-testing/
LOCATION:Park Hyatt Melbourne\, 1 Parliament Square\, Melbourne\, VIC\, 3002\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20241009T090000
DTEND;TZID=America/Los_Angeles:20241009T163000
DTSTAMP:20240926T171511Z
CREATED:20240926T165550Z
LAST-MODIFIED:20240926T171511Z
UID:61838-1728464400-1728491400@globalbiodefense.com
SUMMARY:The Changing DEI Legislation and Policy Landscape and Its Impact on Health and Public Health’s Workforce
DESCRIPTION:The National Academies Roundtable on the Promotion of Health Equity will host a public hybrid workshop on October 9\, 2024 in Washington\, DC to explore the impact of DEI legislation and policies on achieving a diverse health care and public health workforce. \nFollowing the June 2023 Supreme Court ruling against affirmative action in colleges and universities\, many states introduced legislation in higher education to disband DEI efforts. As of August 2024\, 86 bills in 28 states have introduced DEI legislation for colleges and universities to disband diversity offices or staff\, ban mandatory diversity training\, prohibit institutions to use diversity statements in hiring and promotion\, or bar colleges for considering race\, sex\, ethnicity\, or national origin in admissions or employment. \nSpeakers will explore recent changes in state legislature and policies affecting the health care and public health workforce; examine the impact of these policy changes on medical and public health training\, curriculum\, and health research; discuss student recruitment and faculty recruitment and retention for educating and training the health and public health’s workforce; and investigate potential solutions for mitigating adverse impacts of policy changes. \nTo register\, please visit the National Academies’ Exploring the Changing Diversity\, Equity\, and Inclusion Legislation and Policy Landscape and Its Impact on Health and Public Health’s Workforce\, Education\, Training\, and Research: A Workshop page.
URL:https://globalbiodefense.com/event/the-changing-dei-legislation-and-policy-landscape-and-its-impact-on-health-and-public-healths-workforce/
LOCATION:Keck Center\, 500 5th Street Northwest\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241011T110000
DTEND;TZID=America/New_York:20241011T130000
DTSTAMP:20240926T205017Z
CREATED:20240926T204624Z
LAST-MODIFIED:20240926T205017Z
UID:61846-1728644400-1728651600@globalbiodefense.com
SUMMARY:Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3
DESCRIPTION:The Committee to Review the CDC’s COVID-19 Vaccine Safety Research and Communications will host a two-hour public comment session on 11 October 2024. \nPre-registered attendees will have the opportunity to provide virtual public comments and suggestions on how to improve CDC’s vaccine safety research\, and how to make vaccine safety and risk information better and easier to understand. \nComments and suggestions can pertain to vaccines used in emergencies\, like COVID-19\, and vaccines used in non-emergency situations (MMR\, polio\, etc.). \nLearn more at the National Academies’ Review of CDC COVID-19 Vaccine Safety Research and Communications Meeting 3 (part 1). \n\nBackground \nAn ad hoc committee of the National Academies of Sciences\, Engineering\, and Medicine will evaluate the Centers for Disease Control and Prevention (CDC) Immunization Safety Office (ISO) systems\, methods\, and processes for monitoring COVID-19 vaccine safety during the U.S. COVID-19 vaccination program and provide recommendations for sustaining\, maintaining\, and strengthening CDC ISO current monitoring systems moving forward. \nSpecifically\, the committee will assess the statistical and epidemiological methods and processes employed to detect and evaluate potential safety problems with the U.S. COVID-19 vaccines; catalog the findings from safety monitoring including pertinent positive and negative findings; and evaluate CDC external communications about its safety monitoring systems\, the findings of COVID-19 vaccine safety monitoring\, and vaccination and clinical guidance recommendations to healthcare professionals\, public health officials\, and the public. \nSource: National Academies \n 
URL:https://globalbiodefense.com/event/review-of-cdc-covid-19-vaccine-safety-research-and-communications-meeting-3/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241017T190000
DTEND;TZID=America/New_York:20241017T190000
DTSTAMP:20241014T181339Z
CREATED:20241014T181306Z
LAST-MODIFIED:20241014T181339Z
UID:61930-1729191600-1729191600@globalbiodefense.com
SUMMARY:Biodefense MS Information Session
DESCRIPTION:Master of Biodefense Information Session: Prospective students are invited to attend an information session on 17 October 2024 to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn more about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats \nThis session admissions will be led by the Graduate Admissions team. \nAfter registering\, you will receive an email with a zoom link the morning of the session. \nVisit the list of ongoing events at the Schar School here.
URL:https://globalbiodefense.com/event/biodefense-ms-information-session/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241024
DTSTAMP:20240926T172758Z
CREATED:20240926T172607Z
LAST-MODIFIED:20240926T172758Z
UID:61840-1729555200-1729727999@globalbiodefense.com
SUMMARY:Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1)
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will organize a public workshop  on the Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) from 22-23 October 2024 via webcast. \nThe workshop discussions may help inform future research that could provide local\, national\, and global communities with information about virus transmission\, mitigation of risks\, and appropriate measures to prevent the spread of disease. \nKey concepts discussed include: \n\nWhat is the relevant scientific evidence and state of current scientific knowledge?\nWhat research is ongoing and what new results can be anticipated?\nWhat gaps remain and what research should be initiated?\n\nPlease visit the National Academies’ Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1) workshop website for more information. \n\nCall for Public Comment: \nThis Online Public Comment Portal is available for public comments and resource submissions to the workshop planning committee. Information that is submitted will remain confidential and be accessible only to project staff and the planning committee. \nComments may be submitted until October 23\, 2025\, at 11:59 PM ET.
URL:https://globalbiodefense.com/event/potential-research-priorities-to-inform-readiness-and-response-to-highly-pathogenic-avian-influenza-a-h5n1/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241024T130000
DTEND;TZID=America/New_York:20241024T143000
DTSTAMP:20240926T205001Z
CREATED:20240926T204928Z
LAST-MODIFIED:20240926T205001Z
UID:61848-1729774800-1729780200@globalbiodefense.com
SUMMARY:A Long COVID Diagnosis: Implications for Social\, Behavioral\, and Economic Sciences
DESCRIPTION:A Long COVID diagnosis has far-reaching impacts on individuals and communities. While most people recover fully from COVID-19\, tens of millions continue to experience debilitating symptoms that affect their daily lives\, including persistent fatigue\, cognitive challenges\, and social isolation. As these challenges persist\, it is crucial to understand and address the social and behavioral dimensions of Long COVID to improve the well-being and quality of life of those affected \nThis webinar\, hosted by the Societal Experts Action Network in partnership with the National Academies’ Health and Medicine Division\, will bring together leading experts\, patient advocates\, and policymakers to discuss the implications of the newly defined Long COVID condition. This event will focus on the psychosocial aspects of the condition\, examining how it affects identity\, social support\, and community engagement. \nPlease visit the National Academies’ A Long COVID diagnosis: Implications for social\, behavioral\, and economic sciences event page for more information.
URL:https://globalbiodefense.com/event/a-long-covid-diagnosis-implications-for-social-behavioral-and-economic-sciences-2/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241111
DTEND;VALUE=DATE:20241114
DTSTAMP:20240505T173640Z
CREATED:20240505T173640Z
LAST-MODIFIED:20240505T173640Z
UID:61165-1731283200-1731542399@globalbiodefense.com
SUMMARY:Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers
DESCRIPTION:The Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers conference will be held 11-13 November 2024 in Trieste\, Italy. \nJoin world-renowned scientists discussing the known and emerging viruses representing a potential epidemic risk. \nThe event will focus on prevention\, surveillance\, detection\, drug discovery\, treatment\, and cooperation\, to tackle challenges and implementing response strategies related to the threat posed by potential pandemic outbreaks. \nHighlighted topics include: \n\nEmerging and re-emerging viruses with pandemic potential\nRisk of viral zoonoses and its mitigation\nDiagnostics\, surveillance and capacity building in resources limited settings\nImmunization and preventive approaches\nDrug discovery: stocking the shelves for the next pandemic\nBiosafety and Biosecurity when dealing with viral infections\nMultidisciplinary approaches\, infrastructure\, and cooperation\nFuture challenges in pandemic preparedness\n\nThe conference is organized by Area Science Park\, in conjunction with the International Centre for Genetic Engineering and Biotechnology – ICGEB\, in the framework of PRP@CERIC project. \nPlease visit the Pandemic Preparedness: Achievements\, Current Challenges\, and New Frontiers website for more information.
URL:https://globalbiodefense.com/event/pandemic-preparedness-achievements-current-challenges-and-new-frontiers/
LOCATION:Savoia Excelsior Palace\, Riva del Mandracchio\, Trieste\, 34124\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241113
DTEND;VALUE=DATE:20241118
DTSTAMP:20240218T222149Z
CREATED:20240218T221646Z
LAST-MODIFIED:20240218T222149Z
UID:60041-1731456000-1731887999@globalbiodefense.com
SUMMARY:ASTMH 2024 - American Society of Tropical Medicine & Hygiene
DESCRIPTION:The American Society of Tropical Medicine & Hygiene will host the ASTMH 2024 Annual Meeting from 13-17 November 2024 in New Orleans\, Louisiana. \nThe meeting is designed for researchers\, professors\, government and public health officials\, military personnel\, travel clinic physicians\, practicing physicians in tropical medicine\, students\, and all healthcare providers working in the fields of tropical medicine\, hygiene\, and global health. \nLast year’s ASTMH Annual Meeting included over 3\,000 total presentations\, with about half being microbe-focused\, 13% vector-focused\, 15% clinically-focused\, 13% globally-focused and 6% intervention-focused. \nLearn more and register for the ASTMH 2024 Annual Meeting.
URL:https://globalbiodefense.com/event/astmh-2024-american-society-of-tropical-medicine-hygiene/
LOCATION:Ernest N. Morial New Orleans Convention Center\, 900 Convention Center Blvd\, New Orleans\, LA\, 70130\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T093000
DTEND;TZID=America/New_York:20241114T170000
DTSTAMP:20241107T191142Z
CREATED:20241107T191142Z
LAST-MODIFIED:20241107T191142Z
UID:61954-1731576600-1731603600@globalbiodefense.com
SUMMARY:Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
DESCRIPTION:The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. \nIn this workshop\, FDA will convene a panel of external experts to discuss the risk of insertional mutagenesis and best practices for ISA method design\, data analysis\, and clinical interpretation. The workshop participants will include research scientists with experience in vector design and ISA\, as well as clinician-scientists with expertise in clinical interpretation of ISA data. \nFocus for this Workshop\nAs of 2024\, twelve approved and hundreds of investigational cell-based gene therapies use integrating viral vectors. While stable integration may have considerable therapeutic benefits\, integration into genomic DNA can alter host gene expression and may contribute to secondary malignancies via insertional mutagenesis. Additionally\, the choice of vector (e.g.\, lentivirus versus gammaretrovirus) and cell substrate (e.g.\, T cells versus CD34+ cells) may also contribute to this risk. \nISA is the established approach to identify vector insertion sites. However\, ISA method design and data interpretation are highly complex and product-specific. Moreover\, ISA methods may be costly and challenging to perform. There is a critical need to understand the best practices for product design and ISA method design\, execution\, and interpretation to facilitate efficient evaluation of complex gene therapy products and protect the public from potential serious adverse events. \nThis workshop will include discussions on the following topics: \n\nEffects of Cell Substrate and Vector Design on the Risk of Vector Insertion-Related Adverse Events\nISA Methodology\, Assay Design\, and Analytical Capabilities\nISA Analysis\, Quality Control\, and Data Reporting\nClinical Follow-Up for Integrating Viral Vectors\nUsing ISA to Inform Clinical Decisions\n\nFor current guidance on the role of ISA in clinical follow-up\, please refer to section V.F “Special Considerations Regarding Integrating Vectors” of the FDA Guidance for Industry “Long Term Follow-Up After Administration of Human Gene Therapy Products” dated January 2020 (https://www.fda.gov/media/113768/download). \n Registration is required.
URL:https://globalbiodefense.com/event/integration-site-analysis-during-long-term-follow-up-for-gene-therapies-with-integrating-viral-vectors/
LOCATION:
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241120
DTSTAMP:20240623T192942Z
CREATED:20240125T194316Z
LAST-MODIFIED:20240623T192942Z
UID:59697-1731888000-1732060799@globalbiodefense.com
SUMMARY:G20 Summit Rio 2024
DESCRIPTION:The G20 Leaders’ Summit is scheduled for 18-19 November 2024\, in Rio de Janeiro\, with the presence of the leaders of the 19 member countries\, plus the African Union and the European Union. \nThe G20 brings together the countries with the largest economies in the world. The member states meet annually to discuss economic\, political and social initiatives. The group defines itself as the main forum for international economic cooperation. \nThe G20 countries account for half the world’s land mass\, two-thirds of the world’s total population\, and a staggering 85% or more of global GDP. These imply both a large magnitude of health burden on the one hand and a depth of experience and strong base of resources on the other. The G20 Health Working Group was established under the German Presidency in 2017 to develop a shared international agenda on issues such as strengthening health-care systems\, reducing malnutrition\, health-crisis management\, and scaling up the fight against pandemics; these are India’s domestic priorities too. \nIn addition to the summit\, more than 100 meetings of working groups and task forces will comprise the G20 event\, both face-to-face and virtual\, at technical and ministerial level\, in the host cities of Brasil’s five regions. The highlight will be the Summit in Rio de Janeiro. \nThe participating countries are Argentina\, Australia\, Brasil\, Canada\, China\, France\, Germany\, India\, Indonesia\, Italy\, Japan\, Mexico\, Republic of Korea\, Republic of South Africa\, Russia\, Saudi Arabia\, Turkey\, United Kingdom and the United States of America\, African Union and European Union. In addition\, invited guest countries and international organizations participate in the G20. Media reports indicate the Presidents of Russia\, China and Mexico will not be in attendance. State leaders from the other member states will likely attend. \nThe G20 troika system was officially adopted at the Cannes Summit (France) in 2011 as the framework for steering the G20 process. The “troika” consists of the current\, previous\, and next G20 presidencies and the three members cooperate with one another in preparing for the G20 Summit. During Brasil’s presidency\, we will work closely together with India (2023 presidency) and South Africa (2025 presidency). \nPlease visit the G20 Brasil 2024 website for more information on the full summit agenda.
URL:https://globalbiodefense.com/event/g20-summit-rio-2024/
LOCATION:Museu de Arte Moderna do Río de Janeiro\, Av. Infante Dom Henrique\, 85\, Rio de Janeiro\, Brazil
END:VEVENT
END:VCALENDAR